Skip to main content

Closed

MNOV: MediciNova, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin-2164.8%

ROIC-32.5%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio9.09×

MediciNova, Inc.

MNOVNASDAQ Global Market·USD·Closed

MediciNova, Inc.

MNOVNASDAQ·USD·Closed

$1.33

−0.75%

$1.33

−$0.01 (0.75%)

52W Range

20thpctl

Volume

0.18×avg

Mkt Cap

65.46MUSD

P/E

-5.7TTM

Div Yield

–ann

52W Range

20thpctl

Volume

0.18×avg

Market Cap

65.46MUSD

P/E Ratio

-5.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings